A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis

NCT03227471 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: IVA
DRUG: TEZ/IVA
DRUG: VX-445
DRUG: Matched Placebo
DRUG: TEZ
DRUG: VX-561
DRUG: VX-445

Sponsor

Vertex Pharmaceuticals Incorporated